Ditefossol Sodium 3% Eye Drops in Patients With Dry Eye
Status:
COMPLETED
Trial end date:
2024-07-25
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the efficacy of 3% diquafosol sodium eye drops in treating dry eye disease (DED) across different age groups using a propensity score-matched longitudinal design.